MedPath

Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression

Not Applicable
Conditions
Periprosthetic Joint Infection
Interventions
Procedure: Single Debridement, Antibiotics and Implant Retention
Procedure: Planned Double Debridement, Antibiotics and Implant Retention
Registration Number
NCT05640336
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this research is to evaluate two different standard of care surgeries in treating periprosthetic joint infection (PJI) after total hip and knee arthroplasty. Researchers are looking at differences in outcomes following single versus planned double debridement, antibiotics, and implant retention (DAIR) for acutely infected total hip arthroplasty (THA), and total knee arthroplasties (TKAs).

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
490
Inclusion Criteria
  • Patients who speak English and are willing to sign the consent form

  • Patients with acute early postoperative infection (symptoms ≤ 4 weeks from surgery; symptoms < 4 weeks in duration) and acute hematogenous infection (greater than 4 weeks from surgery; symptoms < 3 weeks in duration) of a primary total knee or total hip arthroplasty, defined as:

    • A sinus communicating with the prosthesis OR
    • Two positive cultures obtained from the prosthesis OR
    • 4 of 5 criteria: Elevated ESR (> 30mm/hr) and CRP (> 10mg/L); Elevated synovial leukocyte count (>3000 cells/μL) or change of ++ on; leukocyte esterase strip; Elevated synovial neutrophil percentage (> 80%); One positive culture; Positive histological analysis of periprosthetic tissue (> 5 neutrophils per high; Power field in 5 high power fields x 400).
  • OR Patient with an acute infection diagnosed clinically by an orthopedic surgeon treated with DAIR

Read More
Exclusion Criteria
  • Patients with a chronic PJI, defined as: presentation of symptoms > 4 weeks in duration.
  • Revision surgery or previous two-stage reimplantation.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Single DAIR Surgery ArmSingle Debridement, Antibiotics and Implant RetentionSubjects will undergo a single Debridement Antibiotics and Implant Retention (DAIR) surgical procedure, along with IV antibiotics and followed by oral suppressive antibiotics. This method is currently used and considered to be standard of care.
Double DAIR Surgery ArmPlanned Double Debridement, Antibiotics and Implant RetentionSubjects will undergo planned double Debridement Antibiotics and Implant Retention (DAIR) surgical procedure, along with IV antibiotics and followed by oral suppressive antibiotics. This method is currently used and considered to be standard of care.
Primary Outcome Measures
NameTimeMethod
Subjects free from failure1 year following DAIR.

Total number of subjects considered failure free at one year from surgical DAIR procedure. Failure is defined as reoperation for infection within one year from surgical procedure.

Secondary Outcome Measures
NameTimeMethod
Adverse events10 years following DAIR procedure

Total number of subjects to experience adverse events related to either drug or the surgical procedure

10-year surgical revision rate10 years following DAIR procedure

Total number of subjects to require reoperation or revision with or without infection within ten years from the surgical DAIR procedure.

Hospital length of stayApproximately 2 weeks following DAIR procedure

Total number of days subjects were admitted to the hospital

Resource analysisApproximately 2 weeks following DAIR procedure

Hospital admission cost comparison between the two study arms

Readmission within 90 days of the surgical DAIR procedure90 days following DAIR procedure

Total number of subjects to required hospital readmission within 90 days of DAIR.

5-year surgical reoperation rate5 years following DAIR procedure

Total number of subjects to require reoperation or revision with or without infection within five years from the surgical DAIR procedure.

Survivorship10 years following DAIR procedure

Total number of subject deaths post-surgical DAIR procedure

1-year surgical reoperation rate1 year following DAIR procedure

Total number of subjects to require reoperation or revision with or without infection within one year from the surgical DAIR procedure.

Clinical Outcome Scores1, 5, and 10 years following DAIR procedure

Evaluation of patient reported Harris Hip or Knee Society Scores

Trial Locations

Locations (2)

Mayo Clinic Florida

🇺🇸

Jacksonville, Florida, United States

Mayo Clinic Minnesota

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath